Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New principle in cancer treatment found

20.03.2014

Scientists of the Cluster of Excellence CECAD, University of Cologne, have developed a new strategy for cancer treatment.

Tumor growth is dependent on attracting blood vessels, that supply nutrients and oxygen and dispose of metabolic waste. An insufficient blood supply results in significantly reduced tumor growth.

The poisoning of the mitochondria, the cell´s power-plants, inhibits blood vessel growth, but has no effects on existing vessels. For this purpose the scientists used the weak mitochondrial poison Embelin. Selective inhibition of mitochondrial function could represent a fundamentally new therapeutic approach that may help advance the development of cancer treatments.

Cologne, 2014, March 20. A team of researchers from five CECAD departments led by PD Dr. Hamid Kashkar (University Hospital of Cologne, Institute of Clinical Microbiology, Immunology and Hygiene) and Dr. Oliver Coutelle (University Hospital of Cologne, Department of Internal Medicine I) have found a new principle for the treatment of proliferating solid tumors.

Tumors are highly dependent on the growth of blood vessels supplying nutrients and oxygen and excreting CO2 and metabolic waste products. Accordingly, the inhibition of tumor blood vessels by blocking specific vascular growth factors is a strategy that is already being used successfully to treat tumors today.

In close collaboration with Dr. Hue-Tran Hornig-Do and Prof. Dr. Rudolf Wiesner (University Hospital of Cologne, Institut of Vegetative Physiology), the CECCAD team reports in a recent article in EMBO Mol Med, that Embelin, a substance that is used in African traditional medicine, inhibits vessel growth by a novel mechanism.

They showed that Embelin acts as a weak poison for mitochondria, the power plants of cells. They demonstrated that growing blood vessels – but not resting normal blood vessels – are highly dependent on mitochondrial function and have little capacity to compensate for mitochondrial dysfunction induced by Embelin. Together their findings show that Embelin significantly slowed the growth of tumors by inhibiting their blood supply, but had little effect on existing normal blood vessels and other tissues at the concentrations required.

The study was supported by further research in collaboration with Prof. Sabine Eming (University of Cologne, Dermatology). Wound healing experiments demonstrated delayed closure of wounds in the presence of Embelin due to the lack of blood vessel in-growth, providing additional evidence for the effectiveness of Embelin in inhibiting new blood vessel formation.

Experiments in cooperation with Prof. Aleksandra Trifunovic ( CECAD) provide additional support for the dependence of new blood vessels on adequate mitochondrial function. In particular, mitochondrial dysfunction induced by mutation in mitochondrial DNA severely impaired the capacity for vascularisation of implanted artificial plugs, designed to attract new blood vessels.

In summary, the scientists were able to prove that impairment of mitochondrial function provides a fundamentally new approach to inhibit blood vessel growth in solid tumors with little side effects on normal body functions. Prof. Dr. Rudolf Wiesner: „We all feel excited about this new principle that will provide new approaches in the fight against cancer.“

Contact:
Dr. Oliver Coutelle
Email: oliver.coutelle@uk-koeln.de
or
PD Dr. Hamid Kashkar
Email: h.kashkar@uni-koeln.de

Astrid Bergmeister
Leiterin CECAD PR & Marketing
Tel. + 49 (0) 221-478-84043
Email: astrid.bergmeister@uk-koeln.de

Weitere Informationen:

http://www.cecad.uni-koeln.de

Astrid Bergmeister | idw - Informationsdienst Wissenschaft

Further reports about: CECAD blood metabolic mitochondrial nutrients poison tumors vessel

More articles from Life Sciences:

nachricht Why do animals fight members of other species?
24.04.2015 | University of California - Los Angeles

nachricht Is a small artificially composed virus fragment the key to a Chikungunya vaccine?
24.04.2015 | Paul-Ehrlich-Institut - Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fast and Accurate 3-D Imaging Technique to Track Optically-Trapped Particles

KAIST researchers published an article on the development of a novel technique to precisely track the 3-D positions of optically-trapped particles having complicated geometry in high speed in the April 2015 issue of Optica.

Daejeon, Republic of Korea, April 23, 2015--Optical tweezers have been used as an invaluable tool for exerting micro-scale force on microscopic particles and...

Im Focus: NOAA, Tulane identify second possible specimen of 'pocket shark' ever found

Pocket sharks are among the world's rarest finds

A very small and rare species of shark is swimming its way through scientific literature. But don't worry, the chances of this inches-long vertebrate biting...

Im Focus: Drexel materials scientists putting a new spin on computing memory

Ever since computers have been small enough to be fixtures on desks and laps, their central processing has functioned something like an atomic Etch A Sketch, with electromagnetic fields pushing data bits into place to encode data.

Unfortunately, the same drawbacks and perils of the mechanical sketch board have been just as pervasive in computing: making a change often requires starting...

Im Focus: Exploding stars help to understand thunderclouds on Earth

How is lightning initiated in thunderclouds? This is difficult to answer - how do you measure electric fields inside large, dangerously charged clouds? It was discovered, more or less by coincidence, that cosmic rays provide suitable probes to measure electric fields within thunderclouds. This surprising finding is published in Physical Review Letters on April 24th. The measurements were performed with the LOFAR radio telescope located in the Netherlands.

How is lightning initiated in thunderclouds? This is difficult to answer - how do you measure electric fields inside large, dangerously charged clouds? It was...

Im Focus: On the trail of a trace gas

Max Planck researcher Buhalqem Mamtimin determines how much nitrogen oxide is released into the atmosphere from agriculturally used oases.

In order to make statements about current and future air pollution, scientists use models which simulate the Earth’s atmosphere. A lot of information such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

HHL Energy Conference on May 11/12, 2015: Students Discuss about Decentralized Energy

23.04.2015 | Event News

“Developing our cities, preserving our planet”: Nobel Laureates gather for the first time in Asia

23.04.2015 | Event News

HHL's Entrepreneurship Conference on FinTech

13.04.2015 | Event News

 
Latest News

Electrons Move Like Light in Three-Dimensional Solid

24.04.2015 | Materials Sciences

Connecting Three Atomic Layers Puts Semiconducting Science on Its Edge

24.04.2015 | Materials Sciences

Understanding the Body’s Response to Worms and Allergies

24.04.2015 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>